The association of S267F variant on NTCP (SLC10A1), a hepatitis B viral surface receptor, and treatment response with pegylated interferon in chronic hepatitis B patients: a multicenter study

被引：0
|
作者：
Thanapirom, Kessarin [1 ,2 ]
Suksawatamnuay, Sirinporn [1 ,2 ]
Sukeepaisarnjaroen, Wattana [3 ]
Tanwandee, Tawesak [4 ]
Charatcharoenwitthaya, Phunchai [4 ]
Thongsawat, Satawat [5 ]
Leerapun, Apinya [5 ]
Piratvisuth, Teerha [6 ]
Boonsirichan, Rattana [7 ]
Bunchorntavakul, Chalermrat [8 ]
Pattanasirigool, Chaowalit [9 ]
Pornthisarn, Bubpha [10 ]
Tantipanichtheerakul, Supot [11 ]
Sripariwuth, Ekawee [12 ]
Jeamsripong, Woramon [13 ]
Sanpajit, Theeranun [14 ]
Poovorawan, Yong [15 ]
Komolmit, Piyawat [1 ,2 ]
机构：
[1] Div Gastroenterol, Med, Bangkok, Thailand
[2] Ctr Excellence Liver Dis, Med, Bangkok, Thailand
[3] Khon Kaen Univ, Med, Khon Kaen, Thailand
[4] Mahidol Univ, Med, Bangkok, Thailand
[5] Chiang Mai Univ, Med, Bangkok, Thailand
[6] Prince Songkla Univ, Med, Hat Yai, Thailand
[7] Vajira Hosp, Med, Bangkok, Thailand
[8] Rajavithi Hosp, Med, Bangkok, Thailand
[9] Police Gen Hosp, Med, Bangkok, Thailand
[10] Thammasat Univ Hosp, Med, Bangkok, Thailand
[11] Bhumibol Adulyadej Hosp, Med, Bangkok, Thailand
[12] Naresuan Univ, Med, Phitsanulok, Thailand
[13] Buddhachinaraj Hosp, Med, Phitsanulok, Thailand
[14] Phramongkutklao Hosp, Med, Bangkok, Thailand
[15] Chulalongkorn Univ, Pediat, Bangkok, Thailand
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
584
引用
收藏
页码：291A / 291A
页数：1
相关论文
共 50 条
  • [11] Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B
    Guclu, Ertugrul
    Tuna, Nazan
    Karabay, Oguz
    Akhan, Sila
    Bodur, Hurrem
    Ceylan, Bahadir
    Demirdal, Tuna
    Demirdag, Kutbettin
    Demirturk, Nese
    Ekerbicer, Hasan
    Erol, Serpil
    Esen, Saban
    Evirgen, Omer
    Geyik, Mehmet Faruk
    Gunduz, Alper
    Karahocagil, Mustafa Kasim
    Kokoglu, Omer Faruk
    Ozdemir, Davut
    Ozgunes, Nail
    Sargin, Fatma
    Tosun, Selma
    Tutuncu, Ediz
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2014, 8 (12): : 1601 - 1608
  • [12] Association of vitamin-D-related genetic variations and treatment response to pegylated interferon in patients with chronic hepatitis B
    Limothai, Umaporn
    Chuaypen, Natthaya
    Khlaiphuengsin, Apichaya
    Chittmittraprap, Salyavit
    Poovorawan, Yong
    Tangkijvanich, Pisit
    ANTIVIRAL THERAPY, 2017, 22 (08) : 681 - 688
  • [13] Early hepatitis B viral dynamics and end of treatment virological response (ETVR) in chronic hepatitis B/HBeAg (-) patients receiving pegylated interferon alpha-2b and/or lamivudine
    Vassiliadis, T.
    Sypsa, V.
    Mimidis, K.
    Tassopoulos, N. C.
    Chrysagis, D.
    Ketikoglou, I.
    Raptopoulou, M.
    Haida, C.
    Hatzakis, A.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S192 - S192
  • [14] Association of Interferon-gamma Inducible Protein 10 Polymorphism with Treatment Response to Pegylated Interferon in HBeAg-Positive Chronic Hepatitis B
    Tangkijvanich, Pisit
    Limothai, Umaporn
    Chuaypen, Natthaya
    Khlaiphuengsin, Apichaya
    Wasitthankasem, Rujipat
    Poovorawan, Yong
    HEPATOLOGY, 2015, 62 : 1201A - 1201A
  • [15] Association of interferon-gamma inducible protein 10 polymorphism with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B
    Limothai, Umaporn
    Chuaypen, Natthaya
    Khlaiphuengsin, Apichaya
    Posuwan, Nawarat
    Wasitthankasem, Rujipat
    Poovorawan, Yong
    Tangkijvanich, Pisit
    ANTIVIRAL THERAPY, 2016, 21 (02) : 97 - 106
  • [16] Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment
    Li, Ming-Hui
    Zhang, Lu
    Qu, Xiao-Jing
    Lu, Yao
    Shen, Ge
    Wu, Shu-Ling
    Chang, Min
    Liu, Ru-Yu
    Hu, Lei-Ping
    Li, Zhen-Zhen
    Hua, Wen-Hao
    Song, Shu-Jing
    Xie, Yao
    CHINESE MEDICAL JOURNAL, 2017, 130 (05) : 559 - 565
  • [17] Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment
    Li Ming-Hui
    Zhang Lu
    Qu Xiao-Jing
    Lu Yao
    Shen Ge
    Wu Shu-Ling
    Chang Min
    Liu Ru-Yu
    Hu Lei-Ping
    Li Zhen-Zhen
    Hua Wen-Hao
    Song Shu-Jing
    Xie Yao
    中华医学杂志英文版, 2017, 130 (05) : 559 - 565
  • [18] THE ANALYSIS OF VIROLOGIC RESPONSE IN COMBINATION TREATMENT WITH PEGYLATED INTERFERON AND NUCLEOSIDE ANALOGUE IN PATIENTS WITH CHRONIC HEPATITIS B
    Kim, Hoon Il
    Kim, Sang Gyune
    Kim, Young Seok
    Tae, Jae Woong
    Kim, Boo Sung
    HEPATOLOGY, 2011, 54 : 1050A - 1051A
  • [19] CXCL13 variant predicts pegylated-interferon a treatment response in HBeAg-positive chronic hepatitis B patients
    Luo, Mengqi
    Zhang, Lingyan
    Yang, Chou
    Zhou, Bin
    Hou, Jinlin
    Jiang, De-Ke
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (07)
  • [20] Natural history, outcome, and sustainability of treatment response in chronic viral hepatitis B: multicenter study
    Treeprasertsuk, Sombat
    Tanwandee, Taweesak
    Piratvisuth, Teerha
    Pramoolsinsap, Chutima
    Chutaputti, Anuchit
    Pompininworakij, Kanchana
    Ingsrisawang, Lily
    Mahachai, Varocha
    ASIAN BIOMEDICINE, 2013, 7 (05) : 599 - 607
12345